glp-1 drugs side effects Struggling with therapy effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects Long-Term Effects Of GLP-1 Medications:

But efficacy is only half the story

Kridin K, Amber K, Khamaisi M, Comaneshter D, Batat E, Cohen AD

Retatrutide represents a promising pipeline compound that could expand the therapeutic toolkit, especially for patients with concurrent MASLD/MASH where glucagon-mediated hepatic fat oxidation may provide additional benefit

8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

These results are compelling

Endocrinology and Metabolism 308E414E425